Your browser doesn't support javascript.
loading
Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome.
Bohnert, Bernhard N; Daiminger, Sophie; Wörn, Matthias; Sure, Florian; Staudner, Tobias; Ilyaskin, Alexandr V; Batbouta, Firas; Janessa, Andrea; Schneider, Jonas C; Essigke, Daniel; Kanse, Sandip; Haerteis, Silke; Korbmacher, Christoph; Artunc, Ferruh.
Affiliation
  • Bohnert BN; Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany.
  • Daiminger S; Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University Tübingen, Tübingen, Germany.
  • Wörn M; German Center for Diabetes Research (DZD) at the University Tübingen, Tübingen, Germany.
  • Sure F; Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany.
  • Staudner T; Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany.
  • Ilyaskin AV; Institute of Cellular and Molecular Physiology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Bayern, Germany.
  • Batbouta F; Institute of Cellular and Molecular Physiology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Bayern, Germany.
  • Janessa A; Institute of Cellular and Molecular Physiology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Bayern, Germany.
  • Schneider JC; Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany.
  • Essigke D; Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany.
  • Kanse S; Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany.
  • Haerteis S; Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany.
  • Korbmacher C; Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
  • Artunc F; Institute of Anatomy, University of Regensburg, Regensburg, Germany.
Acta Physiol (Oxf) ; 227(4): e13286, 2019 12.
Article in En | MEDLINE | ID: mdl-31006168
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium / Urokinase-Type Plasminogen Activator / Epithelial Sodium Channels Type of study: Prognostic_studies Limits: Animals Language: En Journal: Acta Physiol (Oxf) Journal subject: FISIOLOGIA Year: 2019 Document type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium / Urokinase-Type Plasminogen Activator / Epithelial Sodium Channels Type of study: Prognostic_studies Limits: Animals Language: En Journal: Acta Physiol (Oxf) Journal subject: FISIOLOGIA Year: 2019 Document type: Article Affiliation country: Germany